ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RPTX Repare Therapeutics Inc

3.45
0.10 (2.99%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Repare Therapeutics Inc RPTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.10 2.99% 3.45 13:00:07
개장가 저가 고가 종가 전일 종가
3.48 3.445 3.74 3.45 3.35
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:05BWDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT..
27/04/202405:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
06/03/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202411:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202411:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202421:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
29/02/202406:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/02/202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202421:10EDGAR2Form 8-K - Current report
28/02/202421:05BWRepare Therapeutics Provides Business Update and Reports..
15/02/202421:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
15/02/202411:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202406:48EDGAR2Form 8-K - Current report
13/02/202406:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
26/01/202404:29EDGAR2Form 8-K - Current report
25/01/202421:00BWRepare Therapeutics Announces Achievement of $40 Million..
13/01/202406:05EDGAR2Form 8-K - Current report
08/01/202421:00BWRepare Therapeutics Provides Corporate Update and Highlights..
05/01/202406:05BWRepare Therapeutics and Debiopharm Partner to Explore the..
30/12/202306:05BWRepare Therapeutics Insiders Establish Automatic Securities..
13/12/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202321:20EDGAR2Form 8-K - Current report
15/11/202321:00BWRepare Therapeutics Unveils Two Programs Expected to Enter..
09/11/202321:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:05EDGAR2Form 8-K - Current report
09/11/202321:00BWRepare Therapeutics Provides Business Update and Reports..
07/11/202321:00BWRepare Therapeutics to Host Investor and Analyst Conference..
06/11/202321:00BWRepare Therapeutics to Participate in Two Upcoming Investor..
14/10/202306:15EDGAR2Form 8-K - Current report
13/10/202322:47EDGAR2Form 8-K - Current report
13/10/202322:40BWRepare Therapeutics Announces Positive Initial Data from..
06/10/202320:56EDGAR2Form 8-K - Current report
03/10/202320:00BWRepare Therapeutics to Host Conference Call and Webcast to..
19/09/202320:00BWRepare Therapeutics to Present Preliminary Phase 1 MYTHIC..
06/09/202320:00BWRepare Therapeutics to Participate at the Morgan Stanley..
10/08/202305:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:09EDGAR2Form 8-K - Current report
10/08/202305:05BWRepare Therapeutics Provides Business Update and Reports..
08/06/202320:00BWRepare Therapeutics to Participate at the Goldman Sachs 44th..
08/06/202305:05BWRepare Therapeutics Reports Proof of Concept for Lunresertib..
06/06/202320:00BWRepare Therapeutics Announces Publication in Nature Medicine..
02/06/202320:00BWRepare Therapeutics to Host Conference Call and Webcast to..
22/05/202320:00BWRepare Reports Inducement Grant Under Nasdaq Listing Rule..
10/05/202305:05BWRepare Therapeutics Provides Business Update and Reports..

최근 히스토리

Delayed Upgrade Clock